For the month of February 2019, Cadence Capital Limited returned a positive gross performance of 3.0% compared to an increase in the All Ordinaries Accumulation Index of 6.1%. For the month, the largest contributors to the Company’s performance were ARQ Group, Macquarie Group, Money3 Corporation, Noni B, Seven Group and Stanmore Coal. The largest detractor from performance was Teva Pharmaceutical.
At 28 February 2019, the Company was 85.8% invested (14.2% cash).
On the 22nd February 2019, the Company announced a 3.0 cent fully franked interim dividend. This equated to a 6.8% annual fully franked yield (9.7% gross yield) based on the CDM share price at the time of the announcement. The Ex-Date for the dividend is the 29th April 2019 and the payment date is the 13th May 2019. The DRP is not operational for the Interim Dividend. For more information please view the Media Release – Half Year Results and Interim Dividend.
Fund NTA
Fund Performance
* Gross Performance: before Management and Performance Fees
CDM Share Price and Option Returns plus Dividends & Franking
Fully Franked Dividends Declared Since Listing
Historic Portfolio Exposure
Portfolio Sector Analysis
Top Portfolio Position
Recent News
The Company released its Half Year webcast on 23rd January 2019. We recommend you watch this webcast where Karl Siegling firstly provides an update on the company’s performance, then discusses in detail our holdings in ARQ Group, Macquarie Group, Money3 Corporation and Noni B Ltd and concludes with the outlook for 2019.
We encourage you to visit our 52 books you should read before buying your next stock page on our website. We have compiled a list of books/ documentaries that have influenced our investment style or helped provide insight into the investment process. To view all previous Cadence webcasts and press articles, please visit the Media Section of the website.
We welcome any of your friends or colleagues that you feel may benefit from our monthly Cadence Capital Limited Newsletter. Please click here to refer a friend by supplying their name and email address.
